On Tuesday, Hologic, Inc (NASDAQ: HOLX) opened lower -0.28% from the last session, before settling in for the closing price of $78.79. Price fluctuations for HOLX have ranged from $67.59 to $84.67 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 6.10%. Company’s average yearly earnings per share was noted 5.48% at the time writing. With a float of $229.01 million, this company’s outstanding shares have now reached $241.71 million.
The extent of productivity of a business whose workforce counts for 6990 workers is very important to gauge. In terms of profitability, gross margin is 55.98%, operating margin of 23.21%, and the pretax margin is 21.47%.
Hologic, Inc (HOLX) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Medical Instruments & Supplies industry is another important factor to consider. The insider ownership of Hologic, Inc is 1.40%, while institutional ownership is 101.16%. The most recent insider transaction that took place on Aug 29 ’24, was worth 4,243,662. In this transaction Chief Financial Officer of this company sold 52,679 shares at a rate of $80.56, taking the stock ownership to the 84,042 shares. Before that another transaction happened on Aug 29 ’24, when Company’s Officer proposed sale 52,679 for $80.56, making the entire transaction worth $4,243,657.
Hologic, Inc (HOLX) Latest Financial update
If we go through the results of last quarter, which was made public on 9/30/2024, the company posted 0.98 earnings per share (EPS) for the quarter, besting the agreed prediction (set at 0.95) by 0.03. Wall Street market experts anticipate that the next fiscal year will bring earnings of 1.07 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 5.48% per share during the next fiscal year.
Hologic, Inc (NASDAQ: HOLX) Trading Performance Indicators
Check out the current performance indicators for Hologic, Inc (HOLX). In the past quarter, the stock posted a quick ratio of 3.03. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 4.53. Likewise, its price to free cash flow for the trailing twelve months is 15.80.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 3.32, a number that is poised to hit 1.02 in the next quarter and is forecasted to reach 4.74 in one year’s time.
Technical Analysis of Hologic, Inc (HOLX)
The latest stats from [Hologic, Inc, HOLX] show that its last 5-days average volume of 1.51 million was inferior to 1.59 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 34.49%. Additionally, its Average True Range was 1.60.
During the past 100 days, Hologic, Inc’s (HOLX) raw stochastic average was set at 48.71%, which indicates a significant increase from 16.56% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 32.00% in the past 14 days, which was higher than the 19.28% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $80.56, while its 200-day Moving Average is $77.56. Now, the first resistance to watch is $79.22. This is followed by the second major resistance level at $79.88. The third major resistance level sits at $80.48. If the price goes on to break the first support level at $77.96, it is likely to go to the next support level at $77.36. The third support level lies at $76.70 if the price breaches the second support level.
Hologic, Inc (NASDAQ: HOLX) Key Stats
There are currently 232,272K shares outstanding in the company with a market cap of 18.25 billion. Presently, the company’s annual sales total 4,030 M according to its annual income of 789,500 K. Last quarter, the company’s sales amounted to 987,900 K and its income totaled 178,600 K.
